Table 3 Association between TyG-WWI index and the risk of stroke according to glucose metabolic states.

From: Association between triglyceride glucose weight adjusted waist index and stroke risk in different glucose metabolism status

Characteristic

Event, n

Model 1

Model 2

Model 3

HR (95% CI)

p-value

HR (95% CI)

p-value

HR (95% CI)

p-value

NGR

 TyG-WWI (Per SD)

270

1.14(1.03, 1.26)

0.008

1.10(0.99, 1.22)

0.081

1.05(0.92, 1.20)

0.487

Quartile

       

 Q1

47

Ref

 

Ref

 

Ref

 

 Q2

58

1.24(0.84, 1.82)

0.274

1.23(0.83, 1.81)

0.299

1.18(0.80, 1.74)

0.407

 Q3

78

1.69(1.17, 2.42)

0.005

1.66(1.15, 2.40)

0.007

1.51(1.03, 2.22)

0.036

 Q4

87

1.90(1.33, 2.71)

< 0.001

1.85(1.26, 2.71)

0.002

1.49(0.97, 2.27)

0.066

 P for trend

  

< 0.001

 

< 0.001

 

0.040

Pre-DM

 TyG-WWI (Per SD)

377

1.32(1.17, 1.48)

< 0.001

1.33(1.18, 1.51)

< 0.001

1.19(1.04, 1.37)

0.012

Quartile

       

 Q1

62

Ref

 

Ref

 

Ref

 

 Q2

93

1.54(1.11, 2.12)

0.009

1.54(1.11, 2.12)

0.009

1.37(0.98, 1.90)

0.062

 Q3

103

1.70(1.24, 2.33)

< 0.001

1.77(1.28, 2.44)

< 0.001

1.44(1.02, 2.02)

0.037

 Q4

119

1.98(1.46, 2.70)

< 0.001

2.06(1.49, 2.87)

< 0.001

1.52(1.04, 2.22)

0.029

P for trend

  

< 0.001

 

< 0.001

 

0.042

DM

 TyG-WWI (Per SD)

184

1.14(0.98, 1.32)

0.102

1.13(0.97, 1.33)

0.116

1.00(0.85, 1.19)

0.977

Quartile

       

 Q1

37

Ref

 

Ref

 

Ref

 

 Q2

45

1.22(0.79, 1.88)

0.372

1.23(0.79, 1.91)

0.354

1.01(0.65, 1.59)

0.949

 Q3

48

1.32(0.86, 2.03)

0.203

1.33(0.86, 2.07)

0.197

0.99(0.62, 1.59)

0.980

 Q4

54

1.51(0.99, 2.30)

0.053

1.54(1.00, 2.36)

0.051

1.08(0.65, 1.81)

0.758

 P for trend

  

0.050

 

0.050

 

0.781

  1. HR = Hazard Ratio, CI = Confidence Interval.
  2. Model 1: unadjusted for any covariates.
  3. Model 2: adjusted for gender, age, residence, marital status, and education level.
  4. Model 3: adjusted for gender, age, residence, marital status, education level, smoking status, drinking status, hypertension, dyslipidemia, hypertension medications, dyslipidemia medications, height, CRP, BUN, Scr, HDL‑C, and UA.
Back to article page